| Literature DB >> 33614496 |
Aukie Hooglugt1,2, Miesje M van der Stoel1, Reinier A Boon2,3,4, Stephan Huveneers1.
Abstract
Solid tumors are dependent on vascularization for their growth. The hypoxic, stiff, and pro-angiogenic tumor microenvironment induces angiogenesis, giving rise to an immature, proliferative, and permeable vasculature. The tumor vessels promote tumor metastasis and complicate delivery of anti-cancer therapies. In many types of tumors, YAP/TAZ activation is correlated with increased levels of angiogenesis. In addition, endothelial YAP/TAZ activation is important for the formation of new blood and lymphatic vessels during development. Oncogenic activation of YAP/TAZ in tumor cell growth and invasion has been studied in great detail, however the role of YAP/TAZ within the tumor endothelium remains insufficiently understood, which complicates therapeutic strategies aimed at targeting YAP/TAZ in cancer. Here, we overview the upstream signals from the tumor microenvironment that control endothelial YAP/TAZ activation and explore the role of their downstream targets in driving tumor angiogenesis. We further discuss the potential for anti-cancer treatments and vascular normalization strategies to improve tumor therapies.Entities:
Keywords: Angiogenic therapy; TAZ; cancer; endothelium; mechanotransduction; tumor angiogenesis; tumor vasculature; yes-associated protein (YAP)
Year: 2021 PMID: 33614496 PMCID: PMC7890025 DOI: 10.3389/fonc.2020.612802
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244